Angela M. Reiersen

Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19

Eric J. Lenze, Caline Mattar, Charles F. Zorumski et al. · JAMA · 2020 · 517 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Sex and Age Differences in Attention-Deficit/Hyperactivity Disorder Symptoms and Diagnoses: Implications for DSM-V and ICD-11

Ujjwal Ramtekkar, Angela M. Reiersen, Alexandre A. Todorov et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2010 · 479 citations · Full text

Medicine, Psychiatry, Psychology +14

Effect of early treatment with fluvoxamine on risk of emergency care and hospitalisation among patients with COVID-19: the TOGETHER randomised, platform clinical trial

Gilmar Reis, Eduardo Augusto dos Santos Moreira-Silva, Daniela Carla Medeiros Silva et al. · The Lancet Global Health · 2021 · 400 citations · Full text

Pharmacy, Emergency Medicine, Pharmacotherapy +10

Autistic traits in a population‐based ADHD twin sample

Angela M. Reiersen, John N. Constantino, Heather E. Volk et al. · Journal of Child Psychology and Psychiatry · 2007 · 353 citations

Medicine, Psychiatry, Psychology +17

Evidence for Shared Genetic Influences on Self-Reported ADHD and Autistic Symptoms in Young Adult Australian Twins

Angela M. Reiersen, John N. Constantino, Marisa Grimmer et al. · Twin Research and Human Genetics · 2008 · 164 citations · Full text

Life Sciences, Genetics, Psychology +17